{"id":"https://openalex.org/W7020532136","doi":null,"title":"The mechanisms of pro-survival action of NRG1 in brain metastatic HER2+ breast cancer cells","display_name":"The mechanisms of pro-survival action of NRG1 in brain metastatic HER2+ breast cancer cells","publication_year":2022,"publication_date":"2022-12-22","ids":{"openalex":"https://openalex.org/W7020532136"},"language":"en","primary_location":{"id":"pmh:oai:mspace.lib.umanitoba.ca:1993/37048","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1993/37048","pdf_url":null,"source":{"id":"https://openalex.org/S4306400554","display_name":"Mspace (University of Manitoba)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I46247651","host_organization_name":"University of Manitoba","host_organization_lineage":["https://openalex.org/I46247651"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011891686","display_name":"Danyyl Ippolitov","orcid":"https://orcid.org/0000-0002-4258-7677","observed_orcids":["https://orcid.org/0000-0002-4258-7677"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ippolitov, Danyyl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5011891686"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.9340000152587891},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8759999871253967},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.8489999771118164},{"id":"https://openalex.org/keywords/erbb4","display_name":"ErbB4","score":0.7250000238418579},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.8420000076293945},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6899999976158142},{"id":"https://openalex.org/keywords/anti-apoptotic-signaling","display_name":"anti-apoptotic signaling","score":0.7269999980926514},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8799999952316284},{"id":"https://openalex.org/keywords/pi-103","display_name":"PI-103","score":0.7720000147819519},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.5199999809265137},{"id":"https://openalex.org/keywords/xiap","display_name":"XIAP","score":0.9760000109672546},{"id":"https://openalex.org/keywords/bad-phosphorylation","display_name":"Bad phosphorylation","score":0.9359999895095825},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.5109999775886536},{"id":"https://openalex.org/keywords/mitochondrial-damage","display_name":"mitochondrial damage","score":0.5249999761581421},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.6660000085830688},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.7674000263214111},{"id":"https://openalex.org/C2779251935","wikidata":"https://www.wikidata.org/wiki/Q5385089","display_name":"ErbB","level":3,"score":0.695900022983551},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6829000115394592},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4918999969959259},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4828000068664551},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.4805999994277954},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.43540000915527344},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.4235000014305115},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4212000072002411},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.41370001435279846},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4099999964237213},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.39899998903274536},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39649999141693115},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.38100001215934753},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3783000111579895},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3767000138759613},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36340001225471497},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.33570000529289246},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3312999904155731},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3021000027656555},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.2948000133037567},{"id":"https://openalex.org/C2780943970","wikidata":"https://www.wikidata.org/wiki/Q17917202","display_name":"ERBB4","level":4,"score":0.29319998621940613},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2870999872684479},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2863999903202057},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2854999899864197},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2793999910354614},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.262800008058548},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.25920000672340393},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.2524000108242035},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.25}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:mspace.lib.umanitoba.ca:1993/37048","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1993/37048","pdf_url":null,"source":{"id":"https://openalex.org/S4306400554","display_name":"Mspace (University of Manitoba)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I46247651","host_organization_name":"University of Manitoba","host_organization_lineage":["https://openalex.org/I46247651"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392201403","https://openalex.org/W4407353657","https://openalex.org/W2886470545","https://openalex.org/W2968971583","https://openalex.org/W4220952402","https://openalex.org/W3180086639","https://openalex.org/W3094100911","https://openalex.org/W1852676669","https://openalex.org/W2225367658","https://openalex.org/W1989251007"],"abstract_inverted_index":{"Introduction:":[0],"HER2+":[1,29,106],"(ErbB2+)":[2],"breast":[3],"cancer":[4],"(BC)":[5],"patients":[6],"demonstrate":[7,317],"a":[8,33,66,303,324],"high":[9],"incidence":[10],"(30%)":[11],"of":[12,17,20,27,56,68,94,137,179,194,204,210,217,224,232,257,287,321,334],"brain":[13,47,80,114,305,326,336],"metastases":[14,337],"(BM).":[15],"Regardless":[16],"the":[18,25,40,53,61,69,79,113,134,138,162,180,202,208,220,233,245,254,277,285,288,293],"effectiveness":[19,55],"ErbB2":[21,99,314,339],"targeting":[22,340],"therapies":[23],"in":[24,60,78,115,158,169,206,219,248,265,292],"therapy":[26],"primary":[28],"BC,":[30],"BM":[31],"remains":[32],"fatal":[34],"complication.":[35],"Restricted":[36],"drug":[37],"permeability":[38],"across":[39],"blood-brain":[41],"barrier":[42],"and":[43,90,124,161,177,183,250,259,262,280,316],"specific":[44],"tumor-":[45],"and/or":[46,87],"tumor":[48],"microenvironment":[49],"(TME)-derived":[50],"factors":[51],"determine":[52],"low":[54],"ErbB":[57],"targeted":[58],"drugs":[59],"brain.":[62],"Neuregulin-1":[63],"(NRG-1)":[64],"is":[65,73],"member":[67],"EGF":[70],"family":[71],"which":[72],"commonly":[74],"expressed":[75],"by":[76,126,151,155,228],"cells":[77,130],"TME.":[81],"NRG1":[82,147,322],"can":[83,331],"bind":[84],"to":[85,112,133,243,276,309,338],"ErbB3":[86,196,205,218,236],"ErbB4":[88],"receptors":[89],"potentially":[91],"promote":[92],"activation":[93,178],"alternative":[95],"signaling":[96,290],"pathways":[97],"under":[98,197,212,313],"inhibition.":[100],"Results:":[101],"The":[102,214,298],"newly":[103],"established":[104],"patient-derived":[105],"BC":[107,335],"model":[108,308],"(BCBM94)":[109],"that":[110,121,330],"metastasizes":[111],"mice":[116],"forms":[117],"well-circumscribed":[118],"proliferative":[119],"tumors":[120],"are":[122,131],"vascularized":[123],"surrounded":[125],"activated":[127],"astrocytes.":[128],"BCBM94":[129,211,249,301],"sensitive":[132],"pro-apoptotic":[135,181],"actions":[136,270],"reversible":[139],"EGFR/ErbB2":[140],"small":[141],"molecule":[142],"tyrosine":[143],"kinase":[144],"inhibitor":[145,282],"Lapatinib.":[146,213],"mitigated":[148,255],"cytotoxicity":[149],"induced":[150],"Lapatinib,":[152],"as":[153,302,323],"shown":[154],"higher":[156],"viability":[157,209,295],"WST-1":[159],"assays":[160],"preserved":[163],"ability":[164],"for":[165],"long-term":[166],"cell":[167,294,307],"propagation":[168],"clonogenicity":[170],"assays.":[171],"NRG-1":[172,185],"blocked":[173],"Lapatinib-driven":[174],"PARP":[175],"cleavage":[176],"caspases-3/7":[182],"caspase-9.":[184],"also":[186,272],"prevented":[187,273],"Lapatinib-induced":[188],"mitochondrial":[189],"damage.":[190],"rhNRG1":[191,225,238],"rescued":[192],"phosphorylation":[193,264],"kinase-impaired":[195],"combined":[198],"Lapatinib/rhNRG1":[199],"treatment":[200],"suggesting":[201],"involvement":[203],"maintaining":[207],"essential":[215],"role":[216,286,320],"apoptosis":[221,247],"inhibiting":[222],"action":[223],"was":[226,239],"confirmed":[227],"siRNA-mediated":[229],"silencing":[230],"(KD)":[231],"receptor.":[234],"Upon":[235],"knockdown,":[237],"no":[240],"longer":[241],"able":[242],"attenuate":[244],"Lapatinib-mediated":[246],"this":[251],"coincided":[252],"with":[253,274],"rescue":[256],"Survivin":[258],"XIAP":[260],"expression":[261],"BAD":[263],"BCBM94.":[266],"These":[267],"rhNRG1-mediated":[268],"anti-apoptotic":[269,328],"were":[271],"exposure":[275],"multi-targeted":[278],"PI3K-Akt":[279],"mTORC1/C2":[281],"(PI-103)":[283],"confirming":[284],"ErbB3-Akt-mTOR":[289],"axis":[291],"rescue.":[296],"Conclusion:":[297],"findings":[299],"identify":[300],"valuable":[304],"metastasis":[306],"study":[310],"resistance":[311,333],"mechanisms":[312],"inhibition":[315],"an":[318],"important":[319],"powerful":[325],"TME-derived":[327],"factor":[329],"facilitate":[332],"therapies.":[341]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}